Takeda Oncology invites you to participate in this ASH 2025 lymphoma and myeloproliferative neoplasms highlights meeting. C-ANPROM/GB/OG/0941 October 2025

TOPICS COVERED

The Takeda Oncology Medical team invites healthcare professionals from the UK and Ireland working in haemato-oncology to the non-promotional, scientific exchange ASH 2025 Highlights meeting covering lymphoma and myeloproliferative neoplasms. The meeting takes place on Wednesday 14 January 2026, 18:00–21:05 and will be Chaired by Dr Wendy Osborne.

At the meeting, an expert panel of speakers will present their selected abstracts from ASH 2025 which will be followed by an interactive discussion where attendees will have the opportunity to ask questions and debate with speakers. Interaction with the Faculty is strongly encouraged. Topics will include: high- and low-grade lymphoma, Hodgkin lymphoma and myeloproliferative neoplasms

C-ANPROM/GB/OG/0941 October 2025

WHO SHOULD ATTEND?

Healthcare professionals who specialise in haemato-oncology.

C-ANPROM/GB/OG/0941 October 2025

SPEAKERS

• Dr Wendy Osborne (Chair), Freeman Hospital, Newcastle upon Tyne
• Dr Andrew McGregor, Freeman Hospital, Newcastle upon Tyne
• Dr Helen Marr, Freeman Hospital, Newcastle upon Tyne
• Dr Tobias Menne, Freeman Hospital, Newcastle upon Tyne
• Professor Graham Collins, Churchill Hospital, Oxford

This non-promotional, scientific exchange meeting is organised and fully funded by the medical department of Takeda UK Ltd and is intended for healthcare professionals from the UK and Ireland with a clinical speciality in haemato-oncology only. This meeting may include discussion of both investigational and licensed agents and is in no way intended to promote Takeda products.

C-ANPROM/GB/OG/0941 October 2025

For more information,please contact: [email protected].